AMB-8LK

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAMB-8LK

Drug Alias Name90Y-AMB8LK monoclonal antibody (MAT Biopharma)90Y-labelled anti-ferritin monoclonal antibody (MAT Biopharma)yttrium-90 anti-ferritin mAb (MAT Biopharma)Cancer therapy (MAT Biopharma)yttrium-90 anti-ferritin mAb (MAT Biopharma) +[8]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyRadiation-emitting products

Mechanisms of ActionFerritin inhibitors

TargetsFerritin

Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsHodgkin Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMablife

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMablife

Active IndicationsN/A

Inactive IndicationsPancreatic NeoplasmsLiver NeoplasmsHodgkin Disease

Other Information

ATC CodeN/A